Amgen (NASDAQ: AMGN) reported quarterly earnings of $5.58 per share which beat the analyst consensus estimate of $5.11 by 9.2 percent. The company reported quarterly sales of $8.50 billion which missed the analyst consensus estimate of $8.52 billion by 0.19 percent. This is a 23.18 percent increase over sales of $6.90 billion the same period last year.